A Clinical-Pathological Analysis of Drug-Induced Hepatic Injury After Liver Transplantation

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3287-3291

  Zhenglu, W ^a   Hui, L ^a   Shuying, Zh ^a   Wenjuan, C ^a   Zhongyang, Sh ^a  

^a TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CASPOFUNGIN; CHINESE DRUG; CISPLATIN; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; ITRACONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; SULPERAZON; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL EXAMINATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EOSINOPHILIA; FATTY LIVER; FEMALE; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; INFLUENZA; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; SIDE EFFECT;

CHOLESTASIS; FATTY LIVER; HEPATOCYTES; HUMANS; LIVER; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TIME FACTORS; WOUNDS AND INJURIES;

EID: 37049021097     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.08.096     Document Type: Article

References (18)

1. Zhenglu W., Shuying Zh., Congzhong Zh., et al. Pathologic diagnosis of transplantation liver puncture biopsy: clinicopathologic analysis of 906 cases/times. Chin J Organ Transpl 27 (2006) 18
2. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 38 (2004) 44
3. Francisco J.A., Dolores M., Mariano M., et al. Acute and clinically relevant drug-induced liver injury: a population bassed case-control study. Br J Clin Pharmacol 58 (2004) 1365
4. Watkis P.B. Role of cytochromes P450 in drug metabolism and hepatotoxicity. Semin Liver Dis 10 (1990) 235
5. Farrell G.C. Drugs and steatohepatitis. Semin Liver Dis 22 (2002) 185
6. Francisco J.A., Dolores M., Mariano M., et al. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 58 (2004) 1365
7. Stiege B., Fattinger K., Madon J., et al. Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt expot pump (Bsep) of rat liver. Gastroenterol 118 (2000) 422
8. Leist M., Gantner F., Kunstle G., et al. Cytokine-mediated hepatic apoptosis. Rev Physiol Biochem Pharmacol 133 (1998) 109
9. Liu Z.X., and Kaplowitz N. Immune-mediated drug-induced liver disease. Clin Liver Dis 6 (2002) 467
10. Andrade R.J., Lucena M.I., Fernandez M.C., et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterol 129 (2005) 512
11. Lazerow S.K., Abdi M.S., and Lewis J.H. Drug-induced liver disease 2004. Curr Opin Gastroenterol 21 (2005) 283
12. Bjornsson E., and Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42 (2005) 481
13. Ohmori S., Shiraki K., Inoue H., et al. Clinical characteristics and prognostic indicators of drug-induced fulminant hepatic failure. Hepatogastroenterology 50 (2003) 1531
14. Shuying Zh., Zhenglu W., Hui L., et al. Histopathology after orthotopic liver trsplantation: an analysis of 494 liver biopsies. Chin J Clin Exp Pathol 20 (2004) 658
15. Zhenglu W., Shuying Zh., Hui L., et al. Histologic diagnosis of acute rejection after liver transplantation-analysis of 200 case/time liverbiopsis. Chin Hepatol 9 (2004) 217
16. Zhenglu W., Shuying Zh., Wenjuan C., et al. The early pathological features of hepatic biopsy in chronic rejection after transplatation. Chin Hepatol 11 (2006) 4
17. Zhenglu W., Shuying Zh., Congzhong Zh., et al. Clinicopathological analysis of biliary tract complications on post-liver transplantation patients. Chin J Hepatol 14 (2006) 247
18. Marino G., Zimmerman H.J., and Lewis J.H. Management of drug-induced liver disease. Curr Gastroenterol Rep 3 (2001) 38